Immunic reported $-0.24 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Compugen USD 954K 116K Sep/2025
CSL USD 18M 1000K Dec/2024
Immunic USD -0.24 0.03 Sep/2024
Insmed USD 765K 55K Sep/2024
Quidel USD -10.78 600.01K Sep/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
United Therapeutics USD 46.4M 4.9M Sep/2025